Effectiveness, Safety and Feasibility of HECT-CL, in Quetta, Pakistan (HECT-CL)
Effectiveness, Safety and Feasibility of Thermotherapy With the Hand-held Exothermic Crystallization Thermotherapy for Cutaneous Leishmaniasis (HECT-CL), Device for Cutaneous Leishmaniasis in Quetta, Pakistan
Sponsor: Medecins Sans Frontieres, Netherlands
Terminated
failure rate 91.1%
Other Cutaneous Leishmaniases trials with similar outcome
A PHASE3 clinical study on Cutaneous Leishmaniases, this trial is terminated or withdrawn. The trial is conducted by Medecins Sans Frontieres, Netherlands and has accumulated 7 data snapshots since 2017. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Feb 2019 — Jan 2021 [monthly]
Terminated PHASE3
Status: Suspended → Terminated
-
Jun 2018 — Feb 2019 [monthly]
Suspended PHASE3
▶ Show 2 earlier versions
-
Apr 2018 — Jun 2018 [monthly]
Suspended PHASE3
Status: Not Yet Recruiting → Suspended
-
Aug 2017 — Apr 2018 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Medecins Sans Frontieres, Netherlands
For direct contact, visit the study record on ClinicalTrials.gov .